TP53 and clear cell renal carcinoma: Moreover, inhibition of miRNA-106b through the use of antagomers can enhance p53 promoter and protein activity in renal clear cell carcinoma cells, highlighting the importance of miRNA106-b expression in a possible p53-directed negative regulatory loop [113].